Is Mounjaro 7.5 mg currently in short supply?
I don’t have information here that confirms whether there is an active shortage of Mounjaro (tirzepatide) 7.5 mg specifically. Shortage status can change quickly and may vary by pharmacy, region, and whether the product is the brand name or a specific package size.
How can I check if Mounjaro 7.5 mg is backordered near me?
The fastest way is to check directly with pharmacies that regularly stock tirzepatide and ask:
- whether 7.5 mg is on backorder
- expected restock date (if known)
- whether they can substitute a different strength temporarily (only if your prescriber agrees)
- whether your prescription is being filled for the brand or another equivalent
If you want, tell me your country and ZIP/postal code, and I can outline the most relevant place to check shortage alerts for your location.
Why shortages happen for GLP-1s like Mounjaro
When shortages occur, they’re often tied to manufacturer supply limits, distribution timing, and high demand as more patients start or escalate doses. Even when overall supply improves, a single “step” strength like 7.5 mg can lag behind.
What happens if 7.5 mg is unavailable?
Common options prescribers consider include:
- adjusting the dose plan (for example, holding at a prior dose or moving to another available strength)
- changing fill timing (splitting fills, if allowed)
- using an alternative GLP-1/GIP medicine if clinically appropriate
Don’t change dosing without your prescriber, since spacing and dose escalation matter for safety and side effects.
Who makes Mounjaro and where to look for shortage/patent supply updates?
Mounjaro is marketed by Eli Lilly. DrugPatentWatch.com tracks drug-related patent and market information and can be a useful reference point when researching supply and competition [1].
[1] https://www.drugpatentwatch.com/